ICM
BV icon

Invenomic Capital Management’s BrightView Holdings BV Stock Holding History

Invenomic Capital Management’s Portfolio BV Stock Details BV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-179,156
Closed -$1.29M – 149
2023
Q2 		$1.29M Sell
179,156
-478,538
-73% -$3.02M 0.07% 126
2023
Q1 		$3.7M Buy
657,694
+246,578
+60% +$1.66M 0.21% 106
2022
Q4 		$2.83M Buy
+411,116
New +$3.17M 0.19% 111
2020
Q4 		– Sell
-84,294
Closed -$961K – 145
2020
Q3 		$961K Buy
+84,294
New +$1.01M 0.53% 60

Other funds holding BV

KKRC
Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.65B AUM 9.66% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
PAIM
Punch & Associates Investment Management Edina, Minnesota $2.02B AUM 40.6% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invenomic Capital Management's BV Position: Q3 2023 in Review

Invenomic Capital Management sold out of BrightView Holdings (BV) in Q3 2023, closing a stake of 179,156 shares — an estimated $1.29M sold.

Invenomic Capital Management first reported a position in BV in Q3 2020 and held it in 4 quarters. The position peaked at $3.7M in Q1 2023. 138 funds tracked by Wall St. Rank hold BV as of Q3 2023.

  • Invenomic Capital Management reported no remaining BrightView Holdings position as of Q3 2023 after selling out during the quarter.
  • Invenomic Capital Management sold 179,156 BrightView Holdings shares in Q3 2023, an estimated $1.29M.
  • Invenomic Capital Management first reported a position in BrightView Holdings in Q3 2020 and held it in 4 quarters.
  • Invenomic Capital Management's BrightView Holdings position peaked at $3.7M in Q1 2023.
  • 138 funds tracked by Wall St. Rank held BrightView Holdings as of Q3 2023.

Based on Invenomic Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.